Gender differences in vascular function and insulin sensitivity in young adults.
To examine influence of insulin resistance and other clinical risk factors for the MetS (metabolic syndrome) on vascular structure and function in young adults. This cross-sectional study was conducted in a cohort of young adults (mean age 22 years) and their siblings participating in a longitudinal study of cardiovascular risk (n=370). Insulin sensitivity was determined by euglycaemic insulin clamp. EDD (endothelium-dependent dilation) was determined by flow-mediated dilation using high-resolution ultrasound imaging of the brachial artery. EID (endothelium-independent dilation) was determined by NTG (nitroglycerine)-mediated dilation. The diameter and cIMT (intima-media thickness) of the carotid artery were also measured. There was no significant difference between males and females for age or body mass index. However, males had significantly higher glucose and triacylglycerol (triglyceride) levels, while the females had significantly higher HDL-C (high-density lipoprotein-cholesterol) and insulin sensitivity (13.00 ± 0.33 compared with 10.71 ± 0.31 mg·kg-1 of lean body mass·min-1, P<0.0001). Although peak EDD was significantly lower (6.28 ± 0.26 compared with 8.50 ± 0.28%, P<0.0001) in males than females, this difference was largely explained by adjustment for brachial artery diameter (P=0.15). Peak EID also was significantly lower in males than females (20.26 ± 0.44 compared with 28.64 ± 0.47%, P<0.0001), a difference that remained significantly lower after adjustment for brachial artery diameter. Males had a significantly greater cIMT compared with females (females 0.420 ± 0.004 compared with males 0.444 ± 0.004 mm, P=0.01), but when adjusted for carotid diameter, there was no significant difference (P=0.163). Although there were gender differences in vascular function and structure in the young adult population examined in this study, many of the differences were eliminated simply by adjusting for artery diameter. However, the lower EID observed in males could not be explained by artery diameter. Future studies need to continue to examine influence of gender on EID and other measures of vascular function.
Dengel
Donald R
DR
School of Kinesiology, University of Minnesota, Minneapolis, MN 55455, USA. denge001@umn.edu
Jacobs
David R
DR
Steinberger
Julia
J
Moran
Antoinette M
AM
Sinaiko
Alan R
AR
D000886:Anthropometry / Q000379:methods; D001786:Blood Glucose / Q000378:metabolism; D001916:Brachial Artery / Q000000981:diagnostic imaging / Q000502:physiology; D002339:Carotid Arteries / Q000033:anatomy & histology; D003430:Cross-Sectional Studies; D004730:Endothelium, Vascular / Q000502:physiology*; D005260:Female; D015309:Glucose Clamp Technique; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D012727:Sex Characteristics; D014280:Triglycerides / Q000097:blood; D017539:Tunica Intima / Q000033:anatomy & histology; D017540:Tunica Media / Q000033:anatomy & histology; D014463:Ultrasonography; D014664:Vasodilation / Q000502:physiology; D055815:Young Adult
D001786:Blood Glucose; D014280:Triglycerides
J Pediatr. 2004 May;144(5):620-5
15126996
Atherosclerosis. 1996 Nov 15;127(1):103-12
9006810
Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1007-10
11903304
J Hypertens. 2003 Dec;21(12):2275-80
14654747
J Am Coll Cardiol. 2006 Nov 7;48(9):1865-70
17084264
J Physiol. 2005 Oct 15;568(Pt 2):357-69
16051630
Clin Sci (Lond). 2007 Jul;112(9):493-8
17173543
Diabetes Care. 1999 Jan;22(1):71-7
10333906
J Appl Physiol (1985). 2007 Apr;102(4):1510-9
17170205
Hypertension. 2004 Aug;44(2):134-9
15249547
Atherosclerosis. 1999 Nov 1;147(1):133-8
10525134
Exp Biol Med (Maywood). 2010 Jan;235(1):111-8
20404025
Am J Med Sci. 2004 Jun;327(6):305-9
15201641
Heart. 1997 Jul;78(1):7-8
9290392
Circulation. 2002 Dec 17;106(25):3143-421
12485966
J Am Coll Cardiol. 1998 Jul;32(1):123-7
9669259
Circulation. 2008 May 6;117(18):2361-8
18427135
Am J Cardiol. 1998 Jul 15;82(2):256-8
9678305
Circulation. 1992 Jan;85(1):37-45
1728471
Atherosclerosis. 2008 Mar;197(1):212-6
17462653
Circulation. 1995 Jul 1;92(1):24-30
7788912
Proc Assoc Am Physicians. 1996 Nov;108(6):473-80
8956371
Lancet. 1992 Nov 7;340(8828):1111-5
1359209
Int J Obes Relat Metab Disord. 1996 Jan;20(1):76-82
8788325
Clin Exp Pharmacol Physiol. 2003 Jan-Feb;30(1-2):1-15
12542447
Hypertension. 2006 Oct;48(4):730-6
16923995
J Am Coll Cardiol. 2004 May 19;43(10):1823-7
15145107
J Pediatr. 2001 Nov;139(5):700-7
11713450
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1782-7
17541023
Am J Med. 1998 Jun;104(6):552-8
9674718
J Clin Endocrinol Metab. 2001 Nov;86(11):5389-95
11701712
Circulation. 2004 Feb 10;109(5):613-9
14769683
J Intern Med. 1997 Jun;241(6):507-13
10497627
Eur Heart J. 2008 May;29(9):1198-206
18079136
Circulation. 2005 Apr 19;111(15):1985-91
15837953
Int J Obes Relat Metab Disord. 2004 Jul;28(7):852-7
15170465
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1034-40
10195933
Stroke. 1999 Dec;30(12):2562-7
10582978
Circulation. 2001 Nov 27;104(22):2673-8
11723017
Am J Physiol Heart Circ Physiol. 2009 Jan;296(1):H57-64
19028795
Cardiovasc Res. 1993 Nov;27(11):1939-42
8287400
Lancet. 2001 Oct 27;358(9291):1400-4
11705484
Biochim Biophys Acta. 1990 May 22;1044(2):275-83
2344447
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1927-34
18775852
Ultrasound Med Biol. 2004 Nov;30(11):1447-9
15588955
Diabetes Care. 2004 Oct;27(10):2444-9
15451914
J Appl Physiol (1985). 2004 Aug;97(2):499-508
15064302
Circulation. 1995 Dec 15;92(12):3431-5
8521564